Atrial Rhythms and SVT
Narrow-complex tachycardias that start above the ventricles
Atrial fibrillation (A-fib)
Irregularly irregular, no P wavesCauses: HTN, CAD, HF, valve disease, age, hyperthyroidism, alcohol, sleep apnea, obesity, after heart surgery.
Assess: apical pulse for a full minute (pulse deficit), palpitations, fatigue, dyspnea, dizziness.
- Unstable → synchronized cardioversion.
- Rate control: beta blocker (metoprolol), diltiazem (not in HFrEF), digoxin.
- Rhythm control: cardioversion, amiodarone and others, catheter ablation.
- A-fib ≥48 h or unknown: anticoagulate ≥3 weeks or TEE before elective cardioversion, and ≥4 weeks after.
- Anticoagulation by CHA₂DS₂-VASc score: DOACs preferred over warfarin, except mechanical valve or moderate–severe mitral stenosis (warfarin). Updated
Atrial flutter
Sawtooth wavesP waves replaced by sawtooth flutter waves (best in II, III, aVF); PR not measurable; QRS narrow. A regular narrow rhythm at exactly ~150 → think flutter with 2:1 block.
Treatment: same rules as A-fib (rate control, cardioversion, anticoagulation). Catheter ablation is often curative.
SVT
Sudden start, sudden stopStable: vagal maneuvers (modified Valsalva), then adenosine 6 mg rapid IV push into a proximal IV followed immediately by a 20 mL saline flush; if needed 12 mg. Warn: brief chest pressure, flushing, and a few seconds of asystole on the monitor are expected. Run a strip.
Unstable: synchronized cardioversion.
CHA₂DS₂-VASc (stroke risk in A-fib)
| C CHF | 1 | H Hypertension | 1 |
| A₂ Age ≥75 | 2 | D Diabetes | 1 |
| S₂ Stroke/TIA/thromboembolism | 2 | V Vascular disease (MI, PAD) | 1 |
| A Age 65–74 | 1 | Sc Sex category (female) | 1 |
Anticoagulation recommended at ≥2 (men) or ≥3 (women); considered at 1 (men) or 2 (women).
Adenosine and diltiazem are avoided in A-fib with a wide, very fast, irregular QRS (possible WPW): they can trigger VF.